Sage Journals: Discover world-class research

Open access

Research article

First published 2023

Impact of csDMARDs adherence on clinical remission in patients with new-onset inflammatory arthritis: a prospective cohort study from the ELECTRA database

Anna Zanetti, Antonella Zambon, Carlo A. Scirè [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Review article

First published 2020

Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage

Julien Blaess, Julia Walther, Arthur Petitdemange [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Review article

First published 2024

Monotherapy or combination therapy in PsA: current aspects

Elpida Skouvaklidou, Paraskevi Avgerou, Konstantinos D. Vassilakis [...]

Therapeutic Advances in Musculoskeletal Disease

Retricted access

Review article

First published 2023-4

Upadacitinib for the Treatment of Rheumatoid Arthritis: An Extensive Review

Eric G. Boyce, Edward L. Rogan, May C. Lui

Annals of Pharmacotherapy

Open access

Research article

First published 2016-9

Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor

Paola Conigliaro, Maria Sole Chimenti, Paola Triggianese [...]

Journal of International Medical Research

Open access

Research article

First published 2024

The protocol of a clinical effectiveness trial comparing standard step-up care,early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial

Marion Watson, William Tillett, Deepak Jadon [...]

Therapeutic Advances in Musculoskeletal Disease

Free access

Review article

First published 2016-10

Combination therapy with biologic agents in rheumatic diseases: current and future prospects

Kentaro Inui, Tatsuya Koike

Therapeutic Advances in Musculoskeletal Disease

Open access

Review article

First published 2021

The role of upadacitinib in the treatment of moderate-to-severe active rheumatoid arthritis

Ali Berkant Avci, Eugen Feist, Gerd Rüdiger Burmester

Therapeutic Advances in Musculoskeletal Disease

Retricted access

Research article

First published 2024-04-30

The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug

Calum Marr, Bethany McDowell, Clive Holmes [...]

Journal of Alzheimer’s Disease

Open access

Research article

First published 2021

Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents

Benjamin Fernandez-Gutierrez, Leticia Leon, Alfredo Madrid [...]

Therapeutic Advances in Musculoskeletal Disease

Search results